ConcertAI is a global leader in precision oncology, integrating AI technology, and real-world evidence (RWE) software-as-a-service (SAAS) solutions for life science companies, healthcare providers and medical societies. ConcertAI’s mission is to accelerate insights and outcomes for patients through leading real-world data (RWD), AI solutions and scientific expertise for oncology hematology and urology.

ConcertAI’s advanced research-grade RWD and analytic technologies support decision-making across drug development, clinical trials, precision oncology, visualization, imaging, clinical decision support and evidence-driven patient care.